𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Paclitaxel pharmacodynamics: application of a mechanism-based neutropenia model

✍ Scribed by Gerald J. Fetterly; Judith M. Tamburlin; Robert M. Straubinger

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
136 KB
Volume
22
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The application of mechanism-based PK/PD
The application of mechanism-based PK/PD modeling in pharmacodynamic-based dose selection of muM17, a surrogate monoclonal antibody for efalizumab
✍ Benjamin Wu; Amita Joshi; Song Ren; Chee Ng 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB

muM17 is an anti-mouse CD11a monoclonal antibody (mAb) developed as a surrogate molecule for assessing potential reproductive toxicities of efalizumab, an anti-human CD11a mAb approved for treatment of chronic moderate to severe plaque psoriasis. This article shows the use of a mechanism-based PK/PD